Target intelligence / Profile preview

Ankyrin

Molecular classification
Other (cytoskeletal adaptor protein)
01

Overview

Ankyrins are a family of intracellular adaptor proteins that link integral membrane proteins to the spectrin-actin cytoskeleton in eukaryotic cells[1][2][5]. The ankyrin family is encoded by three genes in mammals—ANK1, ANK2, and ANK3—each producing multiple alternatively spliced variants, typically called Ankyrin-R (erythrocyte ankyrin), Ankyrin-B, and Ankyrin-G[2]. Ankyrins are characterized structurally by 24 tandem ankyrin repeats at the N-terminus—a protein–protein interaction module—followed by domains that bind spectrin, regulate protein interactions, and mediate intracellular signaling[1][2][3][4]. Ankyrins function as scaffold proteins, organizing protein complexes that include membrane transporters (e.g., Na⁺/K⁺ ATPase, voltage-gated sodium and potassium channels), cell adhesion molecules (L1-CAM), and signaling molecules, thus shaping and sustaining specialized plasma membrane domains such as those in neurons (axon initial segment and nodes of Ranvier) and cardiomyocytes[1][2][5]. Dysfunction or mutation of ankyrin genes is implicated in diseases including hereditary spherocytosis (a hemolytic anemia associated with ANK1 mutations), cardiac arrhythmia (ANK2), and may play a role in certain neurological or psychiatric conditions (e.g., ANK3 and bipolar disorder)[1][2][5]. Ankyrin itself is not considered a conventional drug target (such as a receptor, enzyme, ion channel, or transporter), but a structural component and scaffold, and is not currently targeted by any known therapeutic drugs[1][2][5]. Additional notes: - "Ankyrin" is a protein family, not a single defined molecule or a canonical therapeutic target. - The term "ankyrin repeat" describes a protein structural motif found in ankyrins and many other proteins[3][4]. - Each member (ANK1, ANK2, ANK3) may have more precisely defined disease roles and interaction partners. - If a precise target (such as a specific ankyrin subtype or disease-linked isoform) is intended, further context is required to yield structured drug-target data.

Other names
Ankyrin-R (ANK1)Ankyrin-B (ANK2)Ankyrin-G (ANK3)Erythrocyte ankyrinBand 2.1
02

Biological functions

Membrane stabilizationMembrane protein localizationProtein complex organizationSignal transduction
03

Disease associations

Hemolytic anemiaCardiac arrhythmiaNeurological disorders(ANK3) potential association with bipolar disorder

Beyond the preview

Go deeper on Ankyrin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ankyrin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call